1. Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. doi:10.3322/caac.21492
Google Scholar | Crossref | Medline2. Chen, Y, Bieerkehazhi, S, Li, X, Ma, L, Yibulayin, W, Ran, J. Survivin regulates bad gene expression by binding to its promoter and modulates cell cycle and apoptosis in esophageal carcinoma cell. J Oncol. 2021;2021:1-11. doi:10.1155/2021/1384289
Google Scholar | Crossref3. Wu, G, Qian, Z, Guo, J, et al. Ganoderma lucidum extract induces G1 cell cycle arrest, and apoptosis in human breast cancer cells. Am J Chin Med. 2012;40:631-642. doi:10.1142/S0192415X12500474
Google Scholar | Crossref | Medline4. Li, L, Guo, H-J, Zhu, L-Y, Zheng, L, Liu, X. A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial-mesenchymal transition. Phytomedicine. 2016;23:491-497. doi:10.1016/j.phymed.2016.02.019
Google Scholar | Crossref | Medline5. Chen, Y, Lv, J, Li, K, et al. Sporoderm-broken spores of Ganoderma lucidum inhibit the growth of lung cancer: involvement of the Akt/mTOR signaling pathway. Nutr Cancer. 2016;68:1151-1160. doi:10.1080/01635581.2016.1208832
Google Scholar | Crossref | Medline6. Li, K, Na, K, Sang, T, Wu, K, Wang, Y, Wang, X. The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo. Oncol Rep. 2017;38:2803-2813. doi:10.3892/or.2017.6010
Google Scholar | Crossref | Medline7. Thyagarajan, A, Jedinak, A, Nguyen, H, et al. Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer. 2010;62:630-640. doi:10.1080/01635580903532390
Google Scholar | Crossref | Medline | ISI8. Zhong, J, Fang, L, Chen, R, et al. Polysaccharides from sporoderm-removed spores of Ganoderma lucidum induce apoptosis in human gastric cancer cells via disruption of autophagic flux. Oncol Lett. 2021;21:425-460. doi:10.3892/ol.2021.12686
Google Scholar | Crossref | Medline9. Li, Z, Shi, Y, Zhang, X, et al. Screening immunoactive compounds of Ganoderma lucidum spores by mass spectrometry molecular networking combined with in vivo zebrafish assays. Front Pharmacol. 2020;11:287-320. doi:10.3389/fphar.2020.00287
Google Scholar | Crossref | Medline10. Ji, WT, Chen, HR, Lin, CH, Jeng-Woei, L, Ching-Chih, L, Li, J. Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma. PLoS One. 2014;9:88952-88976. doi:10.1371/journal.pone.0088952
Google Scholar | Crossref11. Yoshimura, T, Howard, OM, Ito, T, et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One. 2013;8:e58791-e58824. doi:10.1371/journal.pone.0058791
Google Scholar | Crossref12. Jin, D, Yang, JP, Hu, JH, Wang, LN, Zuo, JL. MCP-1 stimulates spinal microglia via PI3K/akt pathway in bone cancer pain. Brain Res. 2015;1599:158-167. doi:10.1016/j.brainres.2014.12.043
Google Scholar | Crossref | Medline13. Lee, CC, Ho, HC, Su, YC, Lee, MS, Hung, SK, Lin, CH. MCP1-induced epithelial-mesenchymal transition in head and neck cancer by AKT activation. Anticancer Res. 2015;35:3299-3306.
Google Scholar | Medline14. Yang, H, Zhang, Q, Xu, M, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer. 2020;19:41-79. doi:10.1186/s12943-020-01165-x
Google Scholar | Crossref | Medline15. Liss, C, Fekete, MJ, Hasina, R, Lingen, MW. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma. Int J Cancer. 2002;100:283-289. doi:10.1002/ijc.10507
Google Scholar | Crossref | Medline16. Nagoya, H, Futagami, S, Shimpuku, M, et al. Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues. Am J Physiol Gastrointest Liver Physiol. 2014;306:G183-G190. doi:10.1152/ajpgi.00057.2013
Google Scholar | Crossref | Medline17. Raza, U, Saatci, Ö, Uhlmann, S, et al. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. Oncotarget. 2016;7:49859-49877. doi:10.18632/oncotarget.10489
Google Scholar | Crossref | Medline18. International Agency for Research on Cancer . Latest global cancer data: cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020. Accessed November 3, 2021. https://www.iarc.who.int/news-events/latest-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020/
Google Scholar19. Pennathur, A, Gibson, MK, Jobe, BA, Luketich, JD. Oesophageal carcinoma. Lancet. 2013;381:400-412. doi:10.1016/S0140-6736(12)60643-6
Google Scholar | Crossref | Medline | ISI20. Bianconi, V, Sahebkar, A, Atkin, SL, Pirro, M. The regulation and importance of monocyte chemoattractant protein-1. Curr Opin Hematol. 2018;25:44-51. doi:10.1097/MOH.0000000000000389
Google Scholar | Crossref | Medline21. Xie, B, Wang, S, Jiang, N, Li, JJ. Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56-66. doi:10.1016/j.canlet.2018.11.019
Google Scholar | Crossref | Medline22. Huang, T, Guo, J, Lv, Y, et al. Meclofenamic acid represses spermatogonial proliferation through modulating m~6A RNA modification. J Anim Sci Biotechnol. 2019;10:919-930. doi:10.1186/s40104-019-0361-6
Google Scholar | Crossref23. Wang, Q, Li, M, Zhang, X, et al. Upregulation of CDK7 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis. Exp Mol Pathol. 2016;100:514-521. doi:10.1016/j.yexmp.2016.05.001
Google Scholar | Crossref | Medline24. Jiang, M, Shao, ZM, Wu, J, et al. P21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer. 1997;74:529-534. doi:10.1002/(SICI)1097-0215(19971021)74:5<529::aid-ijc9>3.0.CO;2-5
Google Scholar | Crossref | Medline | ISI25. Zhao, G, Wang, H, Xu, C, et al. SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation. Aging. 2016;8:2308-2323. doi:10.18632/aging.101038
Google Scholar | Crossref | Medline26. Singh, SK, Banerjee, S, Acosta, EP, Lillard, JW, Singh, R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 2017;8:17216-17228. doi:10.18632/oncotarget.15303
Google Scholar | Crossref | Medline27. Evan, GI, Vousden, KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342-348. doi:10.1038/35077213
Google Scholar | Crossref | Medline | ISI28. Cichon, MA, Nelson, CM, Radisky, DC. Regulation of epithelial-mesenchymal transition in breast cancer cells by cell contact and adhesion. Cancer Inform. 2015;14:1-13. doi:10.4137/CIN.S18965
Google Scholar | SAGE Journals29. Brown, GT, Murray, GI. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 2015;237:273-281. doi:10.1002/path.4586
Google Scholar | Crossref | Medline | ISI30. Li, D, Ji, H, Niu, X, et al. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/akt/mTOR in breast cancer. Cancer Sci. 2020;111:47-58. doi:10.1111/cas.14230
Google Scholar | Crossref | Medline31. Talbert, EE, Lewis, HL, Farren, MR, et al. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients. J Cachexia Sarcopenia Muscle. 2018;9:358-368. doi:10.1002/jcsm.12251
Google Scholar | Crossref | Medline32. Koga, M, Kai, H, Egami, K, et al. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem Biophys Res Commun. 2008;365:279-284. doi:10.1016/j.bbrc.2007.10.182
Google Scholar | Crossref | Medline | ISI33. Shen, H, Zhang, J, Zhang, Y, et al. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Gene. 2019;698:50-60. doi:10.1016/j.gene.2019.02.044
Google Scholar | Crossref | Medline34. Li, Z, Wang, J, Deng, X, Huang, D, Shao, Z, Ma, K. Compression stress induces nucleus pulposus cell autophagy by inhibition of the PI3K/AKT/mTOR pathway and activation of the JNK pathway. Connect Tissue Res. 2021;62:337-349. doi:10.1080/03008207.2020.1736578
Google Scholar | Crossref | Medline35. Costa, C, Pereira, S, Lima, L, et al. Abnormal protein glycosylation and activated PI3K/akt/mTOR pathway: role in bladder cancer prognosis and targeted therapeutics. PLoS One. 2015;10:e0141253. doi:10.1371/journal.pone.0141253
Google Scholar | Crossref36. Matsushima, M, Kikuchi, E, Matsumoto, K, et al. Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model. Int J Oncol. 2015;47:377-383. doi:10.3892/ijo.2015.2995
Google Scholar | Crossref | Medline37. Houédé, N, Pourquier, P. Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers. Pharmacol Ther. 2015;145:1-18. doi:10.1016/j.pharmthera.2014.06.004
Google Scholar | Crossref | Medline | ISI38. Wei, Y, Li, M, Cui, S, et al. Shikonin inhibits the proliferation of human breast cancer cells by reducing tumor-derived exosomes. Molecules. 2016;21:777-786. doi:10.3390/molecules21060777
Google Scholar | Crossref39. Zhang, XQ, Yao, C, Bian, WH, et al. Effects of astragaloside IV on treatment of breast cancer cells execute possibly through regulation of nrf2 via PI3K/AKT/mTOR signaling pathway. Food Sci Nutr. 2019;7:3403-3413. doi:10.1002/fsn3.1154
Google Scholar | Crossref | Medline40. Guo, ZL, Li, JZ, Ma, YY, et al. Shikonin sensitizes A549 cells to TRAIL-induced apoptosis through the JNK, STAT3 and AKT pathways. BMC Cell Biol. 2018;19:19-29. doi:10.1186/s12860-018-0179-7
Google Scholar | Crossref | Medline41. Timofeeva, OA, Tarasova, NI, Zhang, X, et al. STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain. Proc Natl Acad Sci USA. 2013;110:1267-1272. doi:10.1073/pnas.1211805110
Google Scholar | Crossref | Medline42. Zhang, H, Zhang, D, Luan, X, Xie, G, Pan, X. Inhibition of the signal transducers and activators of transcription (STAT) 3 signalling pathway by AG490 in laryngeal carcinoma cells. J Int Med Res. 2010;38:1673-1681. doi:10.1177/147323001003800512
Google Scholar | SAGE Journals | ISI43. Zhao, Z, Lv, B, Zhang, L, Zhao, N, Lv, Y. miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3. Mol Med Rep. 2017;16:2281-2289. doi:10.3892/mmr.2017.6841
Google Scholar | Crossref | Medline44. Trivedi, R, Maurya, R, Mishra, DP. Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway. Cell Death Dis. 2